Bio-FEM HRT Capsules

• Special blend of herbs for nutritional support of menopausal and post-menopausal women.
• Natural and plant based hormonal support

Serving size: 1 capsule
Number of servings per container: 60

Amounts per serving

• Red Clover (Trifolium pratense 8% Extract) 230 mg.
• Black Cohosh (Cimicifuga racemosa 2.5% Extract) 200 mg.
• Wild Yam (Dioscorea villosa 10:1) 200 mg.
• Dong Quai (Angelica sinensis 6:1) 100 mg.
• Pregnenolone 10 mg.
• Ferulic Acid 25 mg.

Other Ingredients: Cellulose, magnesium stearate, silica.

Suggested Dose: Take 1-4 capsules per day or as directed by your health care professional.

Red Clover (Trifolium pratense) provides a plant source of phytoestrogen isoflavones (genistein, daidzein, formononetin, and biochanin). These isoflavones are typically found in the diet of Asian, Mediterranean and Central American peoples. The actions of these isoflavones include: antioxidant actions, inhibition of various enzymes, and support of various steroidal reproductive hormones. Trifolium isoflavones have been shown to reduce the frequency and severity of hot flashes, promote emotional well-being, and assist in bone health maintenance.

Black Cohosh (Cimicifuga racemosa) main indications for use are: climacteric (menopausal) complaints, premenstrual and dysmenorrheic neurovegetative disorders. Symptoms of hot flashes, vaginal dryness and thinning, night sweats, sleep disturbances, and emotional symptoms have shown positive benefit with the use of Black Cohosh. Luetinizing hormone levels (LH), but not Follicle Stimulation Hormone (FSH), are significantly reduced with Cimicifuga extracts. Cimicifuga extracts may be a suitable alternative to estrogens in women having a partial, and possibly even a complete, hysterectomies. Cimicifuga extracts have been shown to potentiate the effects of tamoxifen and do not possess stimulatory effects on estrogen receptor positive cells. Black Cohosh may help prevent bone loss. Extracts were shown to stimulate bone formation even in ovariectomized rats.

Wild Yam (Dioscorea villosa): is used industrially as the active agent in the half-synthesis of steroid hormones such as progesterone. It has ant-spasmodic actions. A common use is for uterine cramping.

Dong Quai (Angelica Sinensis): does not appear to have estrogenic actions, rather it appears to enhance estrogen regulation. Its traditional use is as a blood tonic, enhancing the circulation, providing energy, vitality and improved resistance to disease.

Pregnenolone: is a natural steroidal hormone found in animal tissues. It is a precursor for the biosynthesis of steroid hormones dehydroepiandrosterone (DHEA) and progesterone. In the ovary, pregnenolone is the precursor to estrogens and progesterone. In the testes, pregnenolone is the precursor to testosterone. In the adrenal glands, pregnenolone is the precursor to aldosterone, DHEA and cortisol. Pregnenolone is also synthesized in the brain where it acts as a neurosteroid.

Ferulic Acid: from gamma-oryzanol has been shown to reduce elevated levels of FSH, LH and prolactin following ovariectomy in rats. According to Kupperman?s index of menopausal symptoms, the symptoms of climacteric disturbance were successfully treated in 85% of the cases.

Not recommended for use during pregnancy, lactation or during therapy with reproductive hormones including estrogen, progesterone and androgen due to possible competitive inhibition.

1. Nestel PJ, Pomeroy S, Kay S, et al. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J Clin Endocrinol Metab 84:895-898, 1999.
2. Biggs DR, Lane GA. Identification of isoflavones colycosin and pseudobaptigenin in Trifolium pratense. Phytochemistry 17:1683-1684, 1978.
3. Baber R, Templeman C, Moreton T. A study of clover extract as a treatment of menopausal symptoms. Abstract presented at the 1st Australasian Menopause Society Congress, October 1998, Perth, Western Australia.
4. Liske E. Therapeutic efficacy and safety of Cimicifuga racemosa for gynecological disorders. Adv Ther 15:45-53, 1998.
5. Duker EM et al. Effects of extracts from Cimicifuga racemosa on gonadotropin release in menopausal women and ovariectomized rats. Planta Med 57(5):420-4, 1991.
6. Lieberman S. A review of the effectiveness of Cimicifuga racemosa (black cohosh)
7. for the symptoms of menopause. J Women?s Health 7(5):525-9, 1998.
8. Lehmann-Willenbrock E et al. [Clinical and endocrinologic examinations of climacteric symptoms following hysterectomy with remaining ovaries.] Zent Gynakol 110:611-8, 1988 (in German)
9. Nesselhut T, Borth S, Kuhn W. Influence of Cimicifuga racemosa extracts with estrogen-like activity on the in vitro proliferation of mamma carcinoma cells. Arch Gynecol Obstet 254:817-8, 1993.
10. Li JX et al. Effects of Cimicifuga rhizoma on serum calcium and phosphate levels in low calcium dietary rats and on bone mineral density in ovariectomized rats. Phytomed 3(4):379-385, 1996.
11. Yaozy C et al. Analysis of the ingredients of Angelical Sinensis. Kexue Tongbao (Foreign Lang. Ed.) 29:560-62, 1984.
12. Akawa Y, Baulieu EE. Neurosteroids: behavioral aspects and physiological implications. J Soc Biol. 193:293-298, 1999.
13. Yamauchi J, Takahara J, Uneki T, Ofiuki T. Inhibition of LH secretion by gamma oryzanol in the rat. Horm Metab Res 13(3):185, 1981.
14. Ishihara M. Effects of gamma oryzanol on serum lipid peroxide level and climacteric disturbances. Asia-Oceania J Obstet Gynaecol 10(3):317, 1984.
15. Werbach MD, Murray MT. Botanical Influences on Illness: A Sourcebook of Clinical Research, 2nd Ed. Third Line Press Inc. Tarzana, CA. 2000.
16. Knight DC, Eden JA. A review of the clinical effects of phytoestrogens. Obstet Genecol 87:897-904, 1996.
17. Tham DM, Gardner CD, Haskell WL. Clinical review 97: Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Endocrinol Metab 83:2223-22235, 1998.
18. Howes L. Update: Isoflavone phyto-oestrogens. Med Observer 1-3, 5 March, 1999.
19. Kardinaal AFM, Morton MS, Bruggemann-Rotgans IEM, van Beresteijn ECH. Phytoestrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr 52:850-855, 1998.